These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27824413)

  • 1. [Not Available].
    Pommer P
    Dtsch Med Wochenschr; 2016 Oct; 141(22):1607. PubMed ID: 27824413
    [No Abstract]   [Full Text] [Related]  

  • 2. [Seven principles in the treatment of vestibular vertigo and results of the study of VIRTUOSO].
    Zamergrad MV; Parfenov VA; Matsnev EI; Morozova SV; Melnikov OA; Sigaleva EE; Antonenko LM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):106-110. PubMed ID: 29376992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Benign Paroxysmal Positional Vertigo: A Comparative Study between Epleys Manouvre and Betahistine.
    Kaur J; Shamanna K
    Int Tinnitus J; 2017 Jun; 21(1):30-34. PubMed ID: 28723599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betahistine in the Treatment of Peripheral Vestibular Vertigo: Results of a Real-Life Study in Primary Care.
    Sanchez-Vanegas G; Castro-Moreno C; Buitrago D
    Ear Nose Throat J; 2020 Jul; 99(6):356-360. PubMed ID: 31111729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is betahistine effective for Ménière’s disease?
    Rosenbaum A; Winter M
    Medwave; 2017 Oct; 17(8):e7068. PubMed ID: 29099816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign paroxysmal positional vertigo: a study of two manoeuvres with and without betahistine.
    Cavaliere M; Mottola G; Iemma M
    Acta Otorhinolaryngol Ital; 2005 Apr; 25(2):107-12. PubMed ID: 16116833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of medical therapy in the prevention of residual dizziness after successful repositioning maneuvers for Benign Paroxysmal Positional Vertigo (BPPV).
    Acar B; Karasen RM; Buran Y
    B-ENT; 2015; 11(2):117-21. PubMed ID: 26563011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient baseline characteristics in an open-label multinational study of betahistine in recurrent peripheral vestibular vertigo: the OSVaLD study.
    Pérez-Garrigues H; Kuessner D; Benecke H
    Curr Med Res Opin; 2007 Nov; 23(11):2753-61. PubMed ID: 17910803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of betahistine dihydrochloride effectiveness in the treatment of vertigo of a different aetiology based on videonystagmography test results].
    Kantor I; Jurkiewicz D
    Pol Merkur Lekarski; 2006 Mar; 20(117):318-21. PubMed ID: 16780265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of betahistine in the treatment of peripheral vertigo.
    Ramos Alcocer R; Ledezma Rodríguez JG; Navas Romero A; Cardenas Nuñez JL; Rodríguez Montoya V; Deschamps JJ; Liviac Ticse JA
    Acta Otolaryngol; 2015; 135(12):1205-11. PubMed ID: 26245698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homeopathic vs conventional treatment of vertigo.
    Sampson WI
    Arch Otolaryngol Head Neck Surg; 2003 Apr; 129(4):497; author reply 498. PubMed ID: 12707212
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of Betahistine by Patient-Reported Outcomes and its Tolerability Profile in Indian Patients with Vestibular Vertigo.
    Kirtane MV; Biswas A
    J Assoc Physicians India; 2017 Apr; 65(4):18-24. PubMed ID: 28527159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-neurological and stabilometric analysis of betahistine (betaserc) efficacy in the patients with vertigo in the rehabilitation period of ischemic stroke].
    Gekht AB; Vialkova AB; Galanov DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():32-8. PubMed ID: 16447551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of vertigo with betaserk in patients with vascular and traumatic cerebral injuries].
    Gusev EI; Nikonov AA; Skvortsova VI; Avakian GN; Gordeeva TN; Katunina EA; Ataian AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(11):19-21. PubMed ID: 9845935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flunarizine and betahistine. Two different therapeutic approaches in vertigo compared in a double-blind study.
    Elbaz P
    Acta Otolaryngol Suppl; 1988; 460():143-8. PubMed ID: 3074614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine.
    Verspeelt J; De Locht P; Amery WK
    Eur J Clin Pharmacol; 1996; 51(1):15-22. PubMed ID: 8880046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Betaserc and improvement of life quality in war veterans].
    Larikova TI; Cherevikova GM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(3):68-70. PubMed ID: 15822746
    [No Abstract]   [Full Text] [Related]  

  • 18. Betahistine in the treatment of vertigo. History and clinical implications of recent pharmacological researches.
    Mira E
    Acta Otorhinolaryngol Ital; 2001 Jun; 21(3 Suppl 66):1-7. PubMed ID: 11677834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betahistine: hallucinations?
    Prescrire Int; 2015 Nov; 24(165):269. PubMed ID: 26688903
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of vertigo with a homeopathic complex remedy compared with usual treatments: a meta-analysis of clinical trials.
    Schneider B; Klein P; Weiser M
    Arzneimittelforschung; 2005; 55(1):23-9. PubMed ID: 15727161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.